Eptifibatide (monoacetate)-Get quote

Description

Eptifibatide monoacetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].—Neuroscience-Neuromodulation–C37H53N11O11S2—-[1]Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42(8):703-20.–1248559-53-6–892.01—-O=C([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(O)=O)NC(CNC([C@H](CCCCNC(N)=N)N3)=O)=O)=O)N4CCC[C@]4(C(N[C@H](C(N)=O)CSSCCC3=O)=O)[H].CC(O)=O–Cardiovascular Disease–10 mM in DMSO–Integrin—-Cytoskeleton–Peptides